Portugal - português - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

sociedade farmacêutica gestafarma, lda. - maçã reineta + manitol + sene - xarope - associação - manitol 0.61 mg/ml ; maçã reineta, extracto 2.7 mg/ml ; sene, extracto 2.35 mg/ml - drugs for constipation - n/a - duração do tratamento: curta ou média duração

União Europeia - português - EMA (European Medicines Agency)

vertex pharmaceuticals (ireland) limited - lumacaftor, ivacaftor - fibrose cística - outros produtos do sistema respiratório - orkambi comprimidos são indicados para o tratamento da fibrose cística (fc) em pacientes com idade entre 6 anos e mais velhos que são homozigotos para a mutação f508del no gene cftr. orkambi granules are indicated for the treatment of cystic fibrosis (cf) in children aged 1 year and older who are homozygous for the f508del mutation in the cftr gene.

União Europeia - português - EMA (European Medicines Agency)

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.

União Europeia - português - EMA (European Medicines Agency)

ge healthcare b.v. - ioflupano (123l) - tomography, emission-computed, single-photon; lewy body disease; parkinson disease; alzheimer disease - radiofármaco de diagnóstico - este medicamento é apenas para uso diagnóstico. datscan é indicado para detectar a perda funcional do neurônio dopaminérgico terminais no corpo estriado:em pacientes adultos com clinicamente incerto síndromes parkinsónicos, por exemplo, aqueles com início de sintomas, a fim de ajudar a diferenciar o tremor essencial de parkinsonianos síndromes relacionadas a idiopática, doença de parkinson, vários sistema de atrofia e progressiva paralisia supranuclear. datscan é incapaz de distinguir entre a doença de parkinson, vários sistema de atrofia e progressiva paralisia supranuclear. em pacientes adultos, para ajudar a diferenciar provável demência com corpos de lewy da doença de alzheimer. datscan é incapaz de discernir entre a demência com corpos de lewy e doença de parkinson demência.

Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

vertex farmaceutica do brasil ltda. - lumacaftor, ivacaftor - outros produtos para o aparelho respiratorio

União Europeia - português - EMA (European Medicines Agency)

siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - antivirais para uso sistêmico - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 e 5. tecovirimat siga should be used in accordance with official recommendations.

União Europeia - português - EMA (European Medicines Agency)

bayer ag - riociguat - hipertensão, pulmonar - anti-hipertensivos para hipertensão arterial pulmonar - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. a eficácia tem sido mostrado em uma pah de população, incluindo aetiologies de idiopática ou hereditários hap ou pah associada a doença do tecido conjuntivo. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.

União Europeia - português - EMA (European Medicines Agency)

mylan pharmaceuticals limited - teriflunomide - esclerose múltipla remitente-recorrente envio - imunossupressores - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Portugal - português - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

accord healthcare, s.l.u. - vinorrelbina - concentrado para solução para perfusão - 10 mg/ml - vinorrelbina, tartarato 13.85 mg/ml - vinorelbine - genérico - duração do tratamento: longa duração

Portugal - português - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

accord healthcare, s.l.u. - micafungina - pó para concentrado para solução para perfusão - 50 mg - micafungina sódica 50.865 mg - micafungin - genérico - duração do tratamento: longa duração